Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Inventory: 2012-2019

Historic Inventory for Ironwood Pharmaceuticals (IRWD) over the last 5 years, with Dec 2019 value amounting to $648,000.

  • Ironwood Pharmaceuticals' Inventory was N/A to $648,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $648,000, marking a year-over-year change of. This contributed to the annual value of $648,000 for FY2019, which is N/A change from last year.
  • As of Q4 2019, Ironwood Pharmaceuticals' Inventory stood at $648,000, which was down 71.80% from $2.3 million recorded in Q3 2019.
  • Ironwood Pharmaceuticals' 5-year Inventory high stood at $5.0 million for Q1 2015, and its period low was $76,000 during Q3 2018.
  • In the last 3 years, Ironwood Pharmaceuticals' Inventory had a median value of $917,000 in 2017 and averaged $1.1 million.
  • As far as peak fluctuations go, Ironwood Pharmaceuticals' Inventory plummeted by 84.13% in 2018, and later soared by 2,923.68% in 2019.
  • Ironwood Pharmaceuticals' Inventory (Quarterly) stood at $5.0 million in 2015, then reached $1.1 million in 2016, then crashed by 32.01% to $735,000 in 2017, then tumbled by 84.13% to $76,000 in 2018, then soared by 2,923.68% to $648,000 in 2019.
  • Its Inventory was $648,000 in Q4 2019, compared to $2.3 million in Q3 2019 and $1.7 million in Q2 2019.